NeuMoDx Molecular

About

NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing

Ann Arbor,Michigan,United States
51 - 100

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $19.99M
Industries: Biotechnology,Health Care,Health Diagnostics,Medical
Founded date: Jan 1, 2012
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: NeuMoDx Molecular, Inc.

NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$66.03M

NeuMoDx Molecular has raised a total of $66.03M in funding over 2 rounds. Their latest funding was raised on May 3, 2018 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
May 3, 2018	Series Unknown	$20.03M	—	—	—	Detail
Apr 29, 2016	Series Unknown	$19.99M	—	—	—	Detail
Apr 1, 2014	Series B	$21M	5	Baird Capital Pfizer Venture Investments Venture Investors	—	Detail
Apr 1, 2012	Series A	$5M	1	Wolverine Venture Fund	—	Detail

Investors

Number of Lead Investors

Number of Investors

4

5

NeuMoDx Molecular is funded by 5 investors. Baird Capital and Pfizer Venture Investments are the most recent investors.

Investor Name	Lead Investor	Funding Round
Baird Capital	Yes	Series B
Pfizer Venture Investments	Yes	Series B
Venture Investors	Yes	Series B
Arboretum Ventures	—	Series B
Wolverine Venture Fund	—	Series B